News Chart Invites Biocore Co., Ltd.

Equities

A216400

KR7216400002

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
7,470 ^KRW	-0.27%		-1.45%	-19.68%

2023	CrystalGenomics Invites Co., LTD. agreed to acquire an 89.95% stake in PROCAGEN from Invites Biocore Co., Ltd. and others for KRW 13.1 billion	CI
2023	Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. for KRW 10 billion	CI

fb3ddbf133527aeee486e32312.uRxn-p5ogqmaReJw-IaUCBriJuXMQ2J40uRNaHSlBsQ.6ms_qu8w1tvMKoUvqdzLZ061VpWgIS0ghYYXOBbvYJ3hSTKw6x_G2dkkuw~4bb6903f660f5c3879b3ee7c0d665e22